TRAITEMENT DE MALADIES ASSOCIÉES À L'EXTRÉMITÉ C TERMINALE D'UNE PROTÉINE INTERAGISSANT AVEC HSP70' (PUCE) PAR INHIBITION DU TRANSCRIT ANTISENS NATUREL DE PUCE
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of 'C terminus of HSP70-Interacting Protein' (CHIP), in particular, by targeting natural antisense polynucleotides of 'C terminus of HSP70-Interacting Protein' (CHIP). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of CHIP.